In ER+ breast tumors MRPS30 expression correlated strongly with expression of genes in the estrogen signaling pathway. MRPS30 expression is increased in response to estrogen in MPE600 cells which are homozygous for the risk allele. This evidence concerns the gene ESR1 and breast neoplasm.